{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-162557","form_type":"8-K","ticker":"COGT","cik":"0001622229","company_name":"Cogent Biosciences, Inc.","filed_at":"2023-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.709235+00:00","generated_at":"2026-06-14T05:51:26.580899+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Cogent Biosciences stockholders approve 6M share increase under 2018 Equity Plan","bullets":["All three director nominees elected: Chris Cain, Arlene Morris, Todd Shegog each received >51% of votes cast.","Proposal to increase shares reserved under 2018 Stock Option Plan by 6,000,000 shares passed with 40,805,846 for, 23,427,202 against.","Ratification of PricewaterhouseCoopers as independent auditor approved with 65,536,975 votes for, 26,688 against.","Record date April 10, 2023: 70,946,790 shares entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-162557","json":"https://secwatch.observer/filing/0001193125-23-162557.json","markdown":"https://secwatch.observer/filing/0001193125-23-162557.md","text":"https://secwatch.observer/filing/0001193125-23-162557.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622229/000119312523162557/0001193125-23-162557-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622229/000119312523162557/d500671d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:51:26.580899+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19f73d55ac2e9601f952debea5d8aa46466364f2","claim":"Cogent Biosciences, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm.","evidence_excerpt":"Proposal 3. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm 65,536,975 26,688 2,800 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312523162557/0001193125-23-162557-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"24f848b5dd1c8231c7ffc83e6d9f2fc63212677a","claim":"Cogent Biosciences, Inc. shareholders approved Election of Directors.","evidence_excerpt":"Proposal 1. Election of Directors • Chris Cain, Ph.D. 52,182,072 12,054,821 1,329,570 • Arlene M. Morris 51,995,228 12,241,665 1,329,570 • Todd Shegog 51,200,110 13,036,783 1,329,570","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312523162557/0001193125-23-162557-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"89d33bf1c447038182def9cef4398858dfef0881","claim":"Cogent Biosciences, Inc. shareholders approved Approval of an increase of 6,000,000 shares reserved for issuance under the 2018 Plan.","evidence_excerpt":"Proposal 2. Approval of an increase of 6,000,000 shares reserved for issuance under the 2018 Plan 40,805,846 23,427,202 3,845 1,329,570","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622229/000119312523162557/0001193125-23-162557-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}